Jessica Fees

Jessica Fees serves as the chief financial officer at Surface Oncology. Jessica is a finance professional with over 20 years of increasing experience and responsibility in the financial and operations disciplines of accounting, financial planning and analysis, tax, and treasury. Prior to Surface, she served as president of Glide Consulting and held senior positions at Aileron Therapeutics and Tokai Pharmaceuticals. Jessica also has experience in non-biotech organizations such as Apple Tree Partners, Old Mother Hubbard, Babcock Power and WR Grace. Jessica began her career at Arthur Andersen, where she was a manager in the attest function. Jessica received a bachelor’s degree from The College of the Holy Cross and earned her CPA in Massachusetts.